SEC Filings

10-K
ARRAY BIOPHARMA INC filed this Form 10-K on 08/11/2017
Entire Document
 

 
 
 
 
Incorporated by Reference
Exhibit Number
 
Description of Exhibit
 
Form
 
File No.
 
Date Filed
10.19
 
First Amendment to the Amended and Restated Deferred Compensation Plan of Array BioPharma Inc.*
 
10-Q
 
001-16633
 
2/6/2006
10.20
 
Research Services Agreement between registrant and Eli Lilly and Company, dated March 22, 2000, as amended**
 
S-1
 
333-45922
 
9/15/2000
10.21
 
Research Agreement between registrant and Amgen Inc., dated as of November 1, 2001**
 
8-K/A
 
001-16633
 
2/6/2002
10.22
 
Lead Generation Collaboration Agreement between registrant and Takeda Chemical Industries, Ltd., dated July 18, 2001**
 
10-Q
 
001-16633
 
11/14/2001
10.23
 
Collaboration and License Agreement between registrant and AstraZeneca AB, dated December 18, 2003**
 
10-Q
 
001-16633
 
2/2/2004
10.24
 
Drug Discovery Collaboration Agreement between registrant and Genentech, Inc., dated December 22, 2003**
 
10-Q
 
001-16633
 
2/2/2004
10.25
 
Second Amendment, dated October 1, 2005, to the Drug Discovery Collaboration Agreement between registrant and Genentech, Inc.**
 
10-Q
 
001-16633
 
2/6/2006
10.26
 
Letter Agreement dated, July 30, 2009, between the registrant and Genentech, Inc.**
 
10-Q
 
001-16633
 
11/2/2009
10.27
 
Sixth Amendment to Drug Discovery Collaboration Agreement, dated as of September 30, 2010, between the registrant and Genentech, Inc.
 
10-Q
 
001-16633
 
11/9/2010
10.28
 
Seventh Amendment to Drug Discovery Collaboration Agreement, dated as of February 10, 2015, between the registrant and Genentech, Inc.**
 
10-Q
 
001-16633
 
5/7/2015
10.29
 
License Agreement, dated August 5, 2011, between the registrant and Genentech, Inc.**
 
10-Q
 
001-16633
 
11/2/2011
10.30
 
Drug Discovery Collaboration Agreement between registrant and InterMune, Inc., dated September 13, 2002, along with Amendment No. 1 dated May 8, 2003, Amendment No. 2 dated January 7, 2004, Amendment No. 3 dated September 10, 2004, Amendment No. 4 dated December 7, 2004, Amendment No. 4A dated March 10, 2005 and Amendment No. 5 dated June 30, 2005**
 
10-K
 
001-16633
 
9/13/2005
10.31
 
Amendment No. 6, dated February 3, 2006, to the Drug Discovery Collaboration Agreement between registrant and InterMune, Inc., dated September 13, 2002**
 
10-K
 
001-16633
 
9/1/2006
10.32
 
Amendment No. 7, dated June 28, 2006, to the Drug Discovery Collaboration Agreement between registrant and InterMune, Inc., dated September 13, 2002**
 
10-K
 
001-16633
 
9/1/2006
10.33
 
Exercise of Option to Extend Funding of Research FTEs, dated August 31, 2006, to the Drug Discovery Collaboration Agreement between registrant and InterMune, Inc., dated September 13, 2002
 
10-Q
 
001-16633
 
11/6/2006
10.34
 
Drug Discovery Agreement between registrant and Ono Pharmaceutical Co., Ltd., dated November 1, 2005**
 
10-Q
 
001-16633
 
2/6/2006
10.35
 
Loan and Security agreement, dated June 28, 2005, by and between registrant and Comerica Bank
 
10-K
 
001-16633
 
9/13/2005
10.36
 
First Amendment to Loan and Security agreement, dated December 19, 2005, by and between registrant and Comerica Bank
 
10-Q
 
001-16633
 
2/6/2006
10.37
 
Second Amendment to Loan and Security Agreement, dated July 7, 2006, between the registrant and Comerica Bank
 
10-Q
 
001-16633
 
11/6/2006
10.38
 
Third Amendment to Loan and Security Agreement, dated June 12, 2008, between the registrant and Comerica Bank
 
10-K
 
001-16633
 
8/12/2010
10.39
 
Fourth Amendment to Loan and Security Agreement, dated March 11, 2009, between the registrant and Comerica Bank
 
10-K
 
001-16633
 
8/12/2010
10.40
 
Fifth Amendment to Loan and Security Agreement, dated September 30, 2009, between the registrant and Comerica Bank
 
8-K
 
001-16633
 
10/5/2009
10.41
 
Sixth Amendment to Loan and Security Agreement, dated March 31, 2010, between the registrant and Comerica Bank
 
8-K
 
001-16633
 
4/6/2010
10.42
 
Seventh Amendment to Loan and Security Agreement, dated June 11, 2011, between the registrant and Comerica Bank
 
10-K
 
001-16633
 
8/12/2011
10.43
 
Eighth Amendment to Loan and Security Agreement, dated December 28, 2012, between the registrant and Comerica Bank
 
10-Q
 
001-16633
 
2/6/2013
10.44
 
Ninth Amendment to Loan and Security Agreement dated June 4, 2013, by and between the registrant and Comerica Bank
 
8-K
 
001-16633
 
6/10/2013